Back to search

Article

The role of Anti-Mullerian hormone in predicting fertilization and pregnancy rates following in vitro fertilization-embryo transfer (IVF-ET) and intracytoplasmic sperm injection (ICSI) cycles at a public fertility centre in Nigeria

2020-09-07

Abstract excerpt

<h4>Objective</h4> To determine the role of Anti-Mullerian Hormone (AMH) in predicting fertilization and pregnancy rates following in vitro fertilization-embryo transfer (IVF-ET) and intracytoplasmic sperm injection (ICSI) treatment cycles. <h4>Methods</h4> This was a prospective cohort study of one hundred and fifty consecutive women undergoing IVF-ET/ICSI that were recruited from February 1, 2017 to October 31...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8df360e4-c5a0-513b-b01e-10166a937cc8
DOI
10.1101/2020.09.07.285718
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The role of Anti-Mullerian hormone in predicting fertilization and pregnancy rates following in vitro fertilization-embryo transfer (IVF-ET) and intracytoplasmic sperm injection (ICSI) cycles at a public fertility centre in NigeriaDOI 10.1101/2020.09.07.285718
Relationship Between Anti-Müllerian Hormone and In Vitro Fertilization-Embryo Transfer in Clinical PregnancySemantic proximity
High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndromeSemantic proximity
Basal serum follicle-stimulating hormone and anti-mullerian hormone are the predictors of poor ovarian response among fertile and infertile women below the age of 40 years&nbsp;Semantic proximity
Anti-Müllerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional StudySemantic proximity
Anti-Müllerian hormone as a predictor of the number of oocytes obtained during in vitro fertilization treatmentsSemantic proximity
Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary SyndromeSemantic proximity
Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.Semantic proximity
Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort studySemantic proximity
AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cyclesSemantic proximity
Anti-Müllerian Hormone and OPU-ICSI Outcome in the MareSemantic proximity
The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle countSemantic proximity
Anti-Mullerian Hormone:<i>Above and Beyond Conventional Ovarian Reserve Markers</i>Semantic proximity
Select a neighboring publication to make it the new centre.